';
CLOSE
Tags Posts tagged with "COVID-19"

COVID-19

0 625
Photo by Alena Shekhovtcova from Pexels

The FDA has approved and authorized for emergency use updated COVID-19 vaccines (2024-2025 formula) that include a monovalent (single) component that corresponds to the omicron variant KP.2 strain of SARS-CoV-2. These vaccines were updated to provide better protection against COVID-19 caused by circulating variants. Two vaccines are available for use in the United States: 2024–2025 Moderna COVID-19 Vaccine and 2024–2025 Pfizer-BioNTech COVID-19 Vaccine. There is no preference for one vaccine over the other when more than one vaccine is recommended for an age group

Who should get the vaccine?

Everyone ages 6 months and older should get the 2024–2025 COVID-19 vaccine. This includes people who have received a COVID-19 vaccine before and people who have had COVID-19. The COVID-19 vaccine helps protect you from severe disease, hospitalization, and death.

It is especially important to get your 2024–2025 COVID-19 vaccine if you are:

  • Ages 65 and older,
  • At high risk for severe COVID-19
  • Have never received a COVID-19 vaccine.
  • Are living in a long-term care facility
  • Are pregnant, breastfeeding, trying to get pregnant, or might become pregnant in the future.
  • Want to lower your risk of getting Long COVID

People who recently had COVID-19:

  • People who recently had COVID-19 may delay getting a COVID-19 vaccine for 3 months.
  • The risk of getting COVID-19 is less likely in the weeks to months following a SARS-CoV-2 infection.

Certain factors could be reasons to get a vaccine sooner rather than later, such as:

  • Personal risk of severe COVID-19
  • Risk of COVID-19 in a family or household member or other close contact
  • local levels of COVID-19 illness

Keep in mind‎:

  • Vaccine protection decreases over time, so it is important to stay up to date with your COVID-19 vaccine.
  • Getting a COVID-19 vaccine is a safer, more reliable way to build protection than getting sick with COVID-19.

0 975

Thursday, May 30, 2024
12:00 pm – 1:00 pm EDT; 11:00 am – 12:00 pm CDT;
10:00 am – 11:00 am MDT; 9:00 am – 10:00 am PDT
Register

Laura Malone, MD, PhD

Dr. Laura Malone is the director of the Pediatric Post-COVID-19 Rehabilitation Clinic at Kennedy Krieger Institute. She is also a physician scientist in Kennedy Krieger’s Center for Movement Studies and an assistant professor of Neurology and Physical Medicine and Rehabilitation at the Johns Hopkins University School of Medicine.

Dr. Malone has a PhD in Biomedical Engineering from Johns Hopkins University and her medical degree from the University of North Carolina. She completed her pediatric neurology residency at Johns Hopkins School of Medicine. Dr. Malone’s clinical practice focuses on the neurological care of children with perinatal stroke, other brain injuries, and long COVID. Her research focuses on understanding complex pediatric disorders and on improving outcomes using mechanistic neurorehabilitation approaches. Regarding COVID-19, Dr. Malone investigates clinical phenotypes of children with persistent symptoms after COVID-19 infection and investigates factors and mechanisms that promote good recovery.

Objectives: At the end of this session, the learner will:

  • Discuss how our understanding of long COVID has evolved over time;
  • Describe guidance regarding assessment and treatment options for children with long COVID; and
  • Identify recovery patterns and factors that influence severity and recovery of children with long COVID.

Audience: This webinar is intended for all interested members of the rehabilitation team.

Level: Intermediate

Certificate of Attendance: Certificates of attendance are available for all attendees. No CEs are provided for this course.

Complimentary webinars are a benefit of membership in IPRC/RCPA. Registration fee for non-members is $179. Not a member yet? Consider joining today.

0 594

Thursday, May 30, 2024
12:00 pm – 1:00 pm EDT; 11:00 am – 12:00 pm CDT;
10:00 am – 11:00 am MDT; 9:00 am – 10:00 am PDT
Register

Laura Malone, MD, PhD

Dr. Laura Malone is the director of the Pediatric Post-COVID-19 Rehabilitation Clinic at Kennedy Krieger Institute. She is also a physician scientist in Kennedy Krieger’s Center for Movement Studies and an assistant professor of Neurology and Physical Medicine and Rehabilitation at the Johns Hopkins University School of Medicine.

Dr. Malone has a PhD in Biomedical Engineering from Johns Hopkins University and her medical degree from the University of North Carolina. She completed her pediatric neurology residency at Johns Hopkins School of Medicine. Dr. Malone’s clinical practice focuses on the neurological care of children with perinatal stroke, other brain injuries, and long COVID. Her research focuses on understanding complex pediatric disorders and on improving outcomes using mechanistic neurorehabilitation approaches. Regarding COVID-19, Dr. Malone investigates clinical phenotypes of children with persistent symptoms after COVID-19 infection and investigates factors and mechanisms that promote good recovery.

Objectives: At the end of this session, the learner will:

  • Discuss how our understanding of long COVID has evolved over time;
  • Describe guidance regarding assessment and treatment options for children with long COVID; and
  • Identify recovery patterns and factors that influence severity and recovery of children with long COVID.

Audience: This webinar is intended for all interested members of the rehabilitation team.

Level: Intermediate

Certificate of Attendance: Certificates of attendance are available for all attendees. No CEs are provided for this course.

Complimentary webinars are a benefit of membership in IPRC/RCPA. Registration fee for non-members is $179. Not a member yet? Consider joining today.

0 570

The Institute on Disabilities has released its Statewide Report, which includes data gathered through the Independent Monitoring for Quality (IM4Q) Project in Pennsylvania during the 2022/23 fiscal year. Following the COVID-19 pandemic, data collection has shifted to a hybrid model, with some interviews taking place in person and others occurring remotely. Questions may be sent via email.

123...28Next Page 1 of 28
© 2021 - Rehabilitation & Community Providers Association